The FDA has approved updated COVID-19 mRNA vaccines from Pfizer-BioNTech and Moderna to target the current KP.2 strain of SARS-CoV-2. The vaccines are available within a week and are recommended for unvaccinated individuals aged 6 months to 4 years and older, with certain age groups advised to receive one or two doses based on their vaccination history. The vaccines are expected to provide protection against the currently circulating variants, with similar side effects to previous mRNA vaccines. The FDA emphasizes the importance of vaccination in preventing COVID-19 and encourages eligible individuals to consider receiving the updated vaccines.
Source link
Updated COVID mRNA Vaccines Get FDA Approval: Here’s What To Know
